Huang David T, Hadian Mehrnaz
CRISMA Laboratory, Department of Critical Care Medicine, Department of Emergency Medicine, University of Pittsburgh, 641 Scaife Hall, Pittsburgh, PA 15261, USA.
Crit Care. 2006;10(6):244. doi: 10.1186/cc5114.
There are many controversial issues surrounding ethics in study design and conduct of human subjects research. In this review we briefly touch on the origin of ethics in clinical research and how the current regulations and standards came into practice. We then discuss current controversies regarding informed consent, conflicts of interest, institutional review boards, and other relevant issues such as innovative procedures and quality improvement projects. The question of whether we need more standards is a very important yet challenging one to which there is no simple answer. We address this question by reviewing and commenting on relevant literature. We conclude that what is needed are not more standards per se, but rather refinement and uniformity of current standards, and their interpretation and application both to protect human subjects and to advance medicine.
在人类受试者研究的设计和实施过程中,围绕伦理存在许多有争议的问题。在本综述中,我们简要探讨临床研究伦理的起源以及当前的法规和标准是如何付诸实践的。然后,我们讨论当前在知情同意、利益冲突、机构审查委员会以及其他相关问题(如创新程序和质量改进项目)方面的争议。我们是否需要更多标准这个问题非常重要但也具有挑战性,没有简单的答案。我们通过回顾和评论相关文献来探讨这个问题。我们的结论是,本身需要的并非更多标准,而是对当前标准的完善和统一,以及它们在保护人类受试者和推动医学发展方面的解释与应用。